News
SATVI researchers Professors Mark Hatherill, Tom Scriba, Dr Bilek, Darboe, Mbandi, Penn-Nicholson have co-authored a research article titled "Plasma Type I IFN Protein Concentrations in Human Tuberculosis." appearing in the Frontiers in Cellular and Infection Microbiology.
Professor Mark Hatherill has co-authored a journal article titled "FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.
We are inviting applications for a postdoctoral fellowship in human immunology to conduct research aimed at identifying lung immune signatures of resistance to natural M.tb infection in a multi-cohort study. NOW CLOSED.
SATVI researchers have just published an article titled: "Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial" appearing in the Lancet Respiratory Medicine journal.
Pages
SATVI Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
GPS coordinates -33.620455, 19.458576
Map to Worcester Field Office